Showing results (71-80 of 89) with videos related to
Sort By:
Pageof 9
American Journal of Hematology|October 1, 1992
Procoagulant activity of endotoxin or tumor necrosis factor activated monocytes is enhanced by IgG from patients with lupus anticoagulantJ F Schved, J C Gris, V Ollivier, et al.The Journal of Cell Biology|July 1, 1989
High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and plateletsE J Gustafson, H Lukasiewicz, Y T Wachtfogel, et al.La Nouvelle Presse Medicale|October 3, 1981
[Autoimmune thrombocytopenic purpura. Clinical and therapeutic retrospective study of 544 cases (author's transl)]G Tobelem, C Chastang, B Asselain, et al.Thrombosis Research|November 15, 1984
Importance of the interaction between plasminogen and fibrin for plasminogen activation by tissue-type plasminogen activatorF W Dunn, K Deguchi, J Soria, et al.American Journal of Hematology|June 1, 1987
Hermansky-Pudlak platelets: further studies on release reaction and protein phosphorylationsF Rendu, J Maclouf, J M Launay, et al.Blood|October 15, 1993
Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structureJ P Collet, J Soria, M Mirshahi, et al.Experimental Hematology|September 1, 1991
Immunocytochemical study of a Ca(2+)-ATPase enzyme in the human megakaryocytic lineageJ F Deschamps, E Bodevin, E Savariau, et al.Journal of Dairy Science|January 1, 1993
Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activitiesA M Fiat, D Migliore-Samour, P Jollès, et al.Biochimie|April 1, 1987
Signal transduction in normal and pathological thrombin-stimulated human plateletsF Rendu, P Marche, J Viret, et al.European Journal of Biochemistry|November 26, 1990
KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reactionE Mazoyer, S Lévy-Toledano, F Rendu, et al.Pageof 9